Company Data
Larimar Therapeutics Inc.
Ticker
LRMR
Current Price
$2.25 -2.17%
Market Cap
$144.1M
Price Target
Refer to Report
Volume
1.2M
52wk Range
$1.61 - $11.2
Overview
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich’s ataxia.